X0303 4/A 2008-01-23 2008-01-25 0 0000713275 PHARMOS CORP PARS 0001106607 JP MORGAN PARTNERS BHCA LP C/O J.P. MORGAN PARTNERS LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001162622 JP MORGAN PARTNERS GLOBAL INVESTORS LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001169890 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001167095 J P MORGAN PARTNERS GLOBAL INVESTORS A LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001169889 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001317638 JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001361608 JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001243235 JPMP MASTER FUND MANAGER L P C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001281161 JPMP GLOBAL INVESTORS L P C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001330534 JPMP CAPITAL CORP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 Class A Common Stock 2845160 D Class A Common Stock 1636484 D Class A Common Stock 360982 D Class A Common Stock 182798 D Class A Common Stock 50529 D Class A Common Stock 20387 D Class A Common Stock 132823 D Class A Common Stock 461147 D Stock Options (Right to Purchase 1.84 2017-01-16 Common A Stock 20000 20000 I (FN9) Stock Options (Right to Purchase 0.35 2008-01-23 4 A 0 20000 0 A 2008-01-23 2018-01-22 Common A Stock 20000 20000 I (FN9) See Exhibit 99.1 The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners (BHCA), L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The Reporting person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown), L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown) II, L.P. The Reporting Person has no pecuniary interest in such securities. These stock options were granted to Srinivas Akkaraju as part of his Director's Compensation package. Mr. Akkaraju is obligated to exercise the options, and transfer any shares issued under the stock options to JPM BHCA, at the request of JPM BHCA. 25% of these stock options will vest on 1/17/08. The remaining 75% of the stock options will vest in twelve (12) quarterly increments thereafter. This filing is being amended to delete an incorrect reference to footnote 10 in Table II, Box 6 which appeared in the previous submission. J.P. Morgan Partners (BHCA), L.P. By: JPMP Master Fund Manager, L.P., its general partner By: JPMP Capital Corp., its general partner By: /s/ Ana Capella Gomez-Acebo 2008-07-03